Ross Moat - Net Worth and Insider Trading

Ross Moat Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ross Moat owns 1 companies in total, including Kiniksa Pharmaceuticals Ltd (KNSA) .

Click here to see the complete history of Ross Moat’s form 4 insider trades.

Insider Ownership Summary of Ross Moat

Ticker	Comapny	Transaction Date	Type of Owner
KNSA	Kiniksa Pharmaceuticals Ltd	2021-04-09	Group VP & Rilonacept GM

Ross Moat Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ross Moat Ownership Network

Ownership Network List of Ross Moat

No Data

Ownership Network Relation of Ross Moat

Ross Moat Owned Company Details

What does Kiniksa Pharmaceuticals Ltd do?

Who are the key executives at Kiniksa Pharmaceuticals Ltd?

Ross Moat is the Group VP & Rilonacept GM of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .

Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary

Over the past 18 months, Ross Moat made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 68,156 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 98,121 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 98,121 shares. During the past 18 months, 175,593 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 175,593 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kiniksa Pharmaceuticals Ltd Insider Transactions

No Available Data

Ross Moat Mailing Address

Above is the net worth, insider trading, and ownership report for Ross Moat. You might contact Ross Moat via mailing address: C/o Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.

Discussions on Ross Moat

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.